|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 20174298.8 (espacenet) (Federated) (European Patent Register), 20160701 | Patent/reg. no. and date | DK/EP 3778607, 20230830 | Publication date | 20210217 | Priority no. and date | US 201562188029 P, 20150702 | EP pub. no. and date |
EP 3778607 20210217 | Effective date | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | Applicant ref. no. | | Inventor | HANAN, Emily, c/o Genentech Inc. 1 DNA Way
South San Francisco, California 94080, US, BRAUN, Marie-Gabrielle, c/o Genentech Inc. 1 DNA Way
South San Francisco, California 94080, US, STABEN, Steven T., c/o Genentech Inc. 1 DNA Way
South San Francisco, California 94080, US, Heald, Robert Andrew, 31 Sheering Mill Lane Sawbridgeworth
Herts, CM21 9LW, GB, Macleod, Calum, 8/9 Spire Green Centre Flex Meadow
Harlow Essex, CM19 5TR, GB, Elliot, Richard, 8/9 Spire Green Centre Flex Meadow
Harlow, Essex CM 19 STR, GB | Representative | | Opponent | | IPC Class | A61K 31/553 (2006.01) , A61P 35/00 (2006.01) , C07D 498/04 (2006.01) | Title | BENZOXAZEPIN OXAZOLIDINONE COMPOUNDS AND METHODS OF USE | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |